+91-22-48913909The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns. TATA India Pharma & Healthcare Fund is a Equity - Sectoral fund launched on 28 Dec 15. It is a fund with High risk and has given a Below is the key information for TATA India Pharma & Healthcare Fund Returns up to 1 year are on Historical performance (Yearly) on absolute basis TATA India PHARMA & Healthcare Fund - G
Scheme Objective
CAGR return of 11.8% since its launch. Return for 2024 was 40.4% , 2023 was 36.6% and 2022 was -8% . NAV as on 12 Dec 25 ₹30.4339 ↑ 0.02 (0.06 %) Net Assets (AUM) as on 31 Oct 2025 ₹1,325 Cr. Launch Date 28 Dec 2015 Category Equity - Sectoral Rating Type Open Ended Fund Risk High AMC Tata Asset Management Limited Alpha Ratio 1.68 Expense Ratio 2.17 % Sharpe Ratio -0.275 Information Ratio 0.56 Benchmark Not Available Min Investment ₹5,000 Min SIP Investment ₹150 Exit Load 0-3 Months (0.25%),3 Months and above(NIL) NAV Price Chart
Returns
Annual Compounded Returns
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 12 Dec 25 Duration Returns 1 Month -1.5% 3 Month -1.8% 6 Month 1.5% 1 Year -0.2% 3 Year 22% 5 Year 16% 10 Year 15 Year Since launch 11.8% Historical Annual Returns
Year Returns 2024 40.4% 2023 36.6% 2022 -8% 2021 19.1% 2020 64.4% 2019 5.5% 2018 -2.6% 2017 4.7% 2016 -14.7% Growth of 10k Over Years
Date Value 30 Nov 20 ₹10,000 30 Nov 21 ₹12,422 30 Nov 22 ₹12,161 30 Nov 23 ₹15,465 30 Nov 24 ₹21,593 30 Nov 25 ₹21,890 
Asset Allocation
Asset Class Value Cash 1.5% Equity 98.5% 
Sector Allocation
Sector Value Health Care 96.33% Basic Materials 2.17% 
Top Securities Holdings / Portfolio
Holdings/Securities
Name Global Industry Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Jan 16 | SUNPHARMADrug Manufacturers - Specialty & Generic 10% ₹127 Cr 751,703
↓ -63,780 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 31 Dec 16 | APOLLOHOSPMedical Care Facilities 5% ₹68 Cr 88,528 HealthCare Global Enterprises Ltd (Healthcare)
Equity, Since 31 Dec 18 | HCGMedical Care Facilities 5% ₹66 Cr 880,171
↓ -62,282 Lupin Ltd (Healthcare)
Equity, Since 30 Nov 17 | 500257Drug Manufacturers - Specialty & Generic 5% ₹65 Cr 330,887 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Jul 25 | MAXHEALTHMedical Care Facilities 5% ₹62 Cr 543,979
↑ 85,255 Torrent Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Aug 22 | TORNTPHARMDrug Manufacturers - Specialty & Generic 5% ₹60 Cr 168,394 Alkem Laboratories Ltd (Healthcare)
Equity, Since 31 Aug 20 | ALKEMDrug Manufacturers - Specialty & Generic 4% ₹59 Cr 106,435 Abbott India Ltd (Healthcare)
Equity, Since 30 Sep 25 | ABBOTINDIADrug Manufacturers - Specialty & Generic 4% ₹53 Cr 18,387
↑ 5,535 Cipla Ltd (Healthcare)
Equity, Since 30 Apr 20 | 500087Drug Manufacturers - Specialty & Generic 4% ₹52 Cr 346,084
↓ -72,784 Ipca Laboratories Ltd (Healthcare)
Equity, Since 31 Aug 16 | 524494Drug Manufacturers - Specialty & Generic 4% ₹47 Cr 370,697
↑ 60,605
Talk to our investment specialistFund Managers
Name Since Tenure Rajat Srivastava 16 Sep 24 1.13 Yr. Custodians
Company Address Deutsche Bank AG 1 Great Winchester Street Registrar & Transfer Agent
Computer Age Management Services Ltd Address New No.10, Old No.178,,Kodambakkam High Road,,Opp. Hotel Palmgrove,,Nungambakkam FAX 91-44-28283610 Email enq_L@camsonline.com Administrator Companies
Company Address Tata Mutual Fund 1903, B-Wing, Parinee Crescenzo,,G-Block, Bandra Kurla Complex, Bandra East Mumbai 400051 Auditors
Company Address Deloitte Haskins & Sells LLP 12, Dr. Annie Besant Road, Opp. Shiv Sagar Estate,,Worli M/s BSR & Co. KPMG House, Kamala Mills Compound,448 Senapati Bapat Marg,Lower Parel All Plan & Options
Fund and Plan NAV 6 Month 1 Year 3 Year 5 Year TATA India Pharma & Healthcare Fund
Normal Dividend, Reinvestment ₹30.4339
↑ 0.02 1.52 % -0.19 % 21.96 % 15.96 % TATA India Pharma & Healthcare Fund
Normal Dividend, Payout ₹30.4339
↑ 0.02 1.52 % -0.19 % 21.96 % 15.96 % TATA India Pharma & Healthcare Fund
Growth ₹30.4339
↑ 0.02 1.52 % -0.19 % 21.96 % 15.96 % Data as on 12 Dec 25
All efforts have been made to ensure the information provided here is accurate. However, no guarantees are made regarding correctness of data.
AMFI Registration No. 112358 | CIN: U74999MH2016PTC282153
Shepard Technologies Pvt. Ltd. (with ARN code 112358) makes no warranties or representations, express or implied, on products offered through the platform. It accepts no liability for any damages or losses, however caused, in connection with the use of, or on the reliance of its product or related services. Terms and conditions of the website are applicable.
©2025 Shepard Technologies Private Limited. All Rights Reserved